S100A8 and Schwartz-Jampel syndrome: Due to contradictory evidence on whether S100A8/A9 amplifies inflammation or exhibits an anti-inflammatory effect, the role of S100A8/A9 expression in the pathogenesis of SJS/TEN needs to be further elucidated.